Skip to main content
NHI logo

NHI · National Health Investors Inc · Financials

Track NHI — free
$64.92 -1.43 (-2.16%) At close · Oct 21
Market Cap
$3.26B
Shares
49.11M
Volume · Oct 21 247.57K Avg daily vol (3M) 353.15K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$375.63M +12.1%
FY2025 Revenue FY2008–FY2025
Net Income
$142.18M +3%
FY2025 Net Income FY2008–FY2025
Operating Margin
65.65% +7.6pp
FY2015 Operating Margin FY2008–FY2015
Diluted EPS
$3.02 -3.5%
FY2025 Diluted EPS FY2008–FY2025
Operating Cash Flow
$236.56M +13.9%
FY2025 Operating Cash Flow FY2008–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
— $432.12M $375.63M $335.18M $319.84M $278.19M $298.72M $332.81M $318.08M $294.61M $278.66M $248.46M $228.95M $177.51M $117.83M $93.32M $83.74M $82.58M $62.79M $56.94M
— $276.24M — — $268.74M $240.21M — — — — — — — — — — — — — —
— $277M $271.6M $257.05M $249.23M $217.7M $271.05M $307.21M $294.18M $280.81M $265.17M $232.35M $214.41M $166.28M $106.03M $81.48M $72.61M $70.92M $53.65M $47.28M
— $30.59M $26.87M $20.74M $19.31M $22.77M $18.43M $13.3M $13.4M $12.55M $12.22M $9.77M $10.52M $9.11M $9.25M $7.8M $7.59M $7.79M $5.26M $3.59M
— — $80.94M $71.44M $69.97M — — — — — — — — — — — — — — —
— — $0 $0 $1.17M $21.53M $6.4M $6.4M $0 — — — — — — — — $0 $25K $1.99M
— $292.65M $238.96M $211.88M $200.88M $241.86M $216.14M $161.77M $156.81M $139.54M $127.17M $129.69M $102.23M $74.37M $41.83M $25.41M $24.18M $21.07M $14.14M $12.3M
— — — — — — — — — — — — $150.31M $103.05M $79.5M $72.83M $69.82M $61.79M $48.66M $44.64M
— — — — — — — — — — — — 65.65% 58.05% 67.47% 78.05% 83.37% 74.82% 77.48% 78.39%
— $58.88M $57.37M $59.9M $58.16M $44.92M $50.81M $52.88M $56.3M $49.06M $46.32M $43.11M $37.63M $26.37M $9.23M $3.49M $3.85M $1.55M — —
— — — — — $24.7M $27.67M $25.6M $23.9M $13.8M $13.49M $16.11M $10.21M $7.01M $7.63M $7.43M $6.65M $6.74M $9.15M $9.67M
— $852K — — — — — — — — — — — — — — $596K $566K $269K —
— — — — — — — — $0 $0 $50K $4.58M $1.13M $0 $22.26M $11.97M $3.35M — — —
— $1.73M $3.66M $402K $555K $569K -$1.55M -$3.13M $0 $0 $0 -$1.21M -$1.77M -$71K $324K $45K $0 $0 — —
— — — — — — — — $161.27M $155.07M $151.49M $118.77M $126.72M $103.14M $76M $67.91M $59.56M $61.51M — —
— — — — — — — — — $138K $124K $854K -$583K $118K $118K $267K $96K $82K — —
— $166.8M $142.18M $137.99M $135.65M $66.4M $111.8M $185.13M $160.46M $154.33M $159.37M $151.54M $148.86M $101.61M $106.18M $90.73M $81.13M $69.42M $64.23M $57.51M
— — 37.85% 41.17% 42.41% 23.87% 37.43% 55.62% 50.45% 52.39% 57.19% 60.99% 65.02% 57.24% 90.12% 97.23% 96.89% 84.07% 102.29% 101%
— -$1.41M -$1.39M -$1.35M -$1.27M -$902K $163K $185K -$7000 $0 $0 $1.18M $1.45M $1.44M $999K $167K $0 $0 — —
— $166.53M $141.98M $137.87M $135.6M $66.4M $111.8M — — — — — — — — — — — — —
— — — — $135.65M $66.4M $118.95M $181.41M $155.73M $156.22M $152.81M $129.36M $170.55M $98.29M $108.17M $91.11M $72.98M $70.65M $67.54M $53.93M
USD/shares — $3.47 $3.03 $3.14 $3.13 $1.48 $2.45 $4.14 $3.70 $3.68 $3.90 $3.88 $3.96 $3.04 $3.74 $3.26 $2.93 $2.51 $2.33 $2.08
USD/shares $14.37 $3.46 $3.02 $3.13 $3.13 $1.48 $2.44 $4.14 $3.67 $3.67 $3.87 $3.87 $3.95 $3.04 $3.74 $3.26 $2.92 $2.50 $2.32 $2.07
shares — — 46.87M 43.84M 43.39M 44.77M 45.71M 44.7M 43.42M 41.94M 40.89M 39.01M 37.6M 33.38M 28.36M 27.81M 27.72M 27.66M 27.59M 27.71M
shares — — 47.05M 44.1M 43.39M 44.79M 45.73M 44.7M 43.7M 42.09M 41.15M 39.16M 37.64M 33.42M 28.4M 27.84M 27.79M 27.73M 27.62M 27.73M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $155.57M in buybacks, $2.33B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Line of credit borrowings, including current maturities 2026-06-30 USD 438,000,000 10-Q filed 2026-08-10
Operating lease liabilities 2026-06-30 USD 3,744,000 10-Q filed 2026-08-10
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
10.42×
Peer median 8.76×
EV/EBIT
—
P/E (TTM)
19.18×
Peer median 24.36×
P/FFO (TTM)
14.29×
Peer median 14.94×

Peer medians compare against the 13 similar-size REIT - Healthcare Facilities companies (of 17 listed).

P/FFO uses the company-stated “NAREIT FFO attributable to common stockholders”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

P/FFO and EV/Adj. EBITDA use the company-stated “NAREIT FFO attributable to common stockholders” and “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Real Estate Investment Segment $295,566,000 $280,292,000 $270,675,000 $242,083,000
Senior Housing Operating Portfolio $80,062,000 $54,421,000 $48,809,000 $35,796,000
Key facts CIK 877860 CUSIP 63633D104 13F (30d) 41 filings 41 filers Visit website Investor relations